Jones Mitchell Lawrence's Form 4 filing
Palisade Bio, Inc. (PALI) · filed Feb 13, 2026
- Accession no.
- 0001493152-26-006833
- Filed
- Feb 13, 2026
- Trade date
- Feb 11-12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.48K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jones Mitchell LawrenceCIK 0001993292 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Common Stock | MOption exerciseAcquired | +8,000 | – | – | 15,252 | Direct | |
| Feb 12, 2026 | Common Stock | SSaleDisposed | −1,989 | $1.75 | −$3,480.75 | 13,263 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 16,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.